ThinkSabio

$HELP

$9.00▲ +2.2% YTD

16 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History
News
HELP ▲ +2.2% - Cybin D/B/A Helus Pharma
CP $9.00▲ +2.2%Nov 3, 2026 · ThinkSabio Blog

$HELP - Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference…

News
HELP ▲ +0.1% - Cybin D/B/A Helus Pharma
CP $10.33▲ +0.1%Oct 27, 2026 · ThinkSabio Blog

$HELP - Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development…

News
HELP ▼ -2.7% - Cybin D/B/A Helus Pharma
CP $10.63▲ -2.7%Oct 21, 2026 · ThinkSabio Blog

$HELP - Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026…

News
HELP ▼ -0.2% - Cybin D/B/A Helus Pharma
CP $10.36▲ -0.2%Oct 15, 2026 · ThinkSabio Blog

$HELP - Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors…

News
HELP ▲ +0.4% - Cybin D/B/A Helus Pharma
CP $10.53▲ +0.4%Oct 8, 2026 · ThinkSabio Blog

$HELP - Helus Pharma to Host Investor Presentation on October 21, 2026…

News
HELP ▲ +1.8% - Cybin D/B/A Helus Pharma
CP $12.50▲ +1.8%Oct 1, 2026 · ThinkSabio Blog

$HELP - Helus Pharma Announces Completion of Legal Name Change…

News
HELP ▲ +1.0% - Cybin D/B/A Helus Pharma
CP $13.80▲ +1.0%Sep 22, 2026 · ThinkSabio Blog

$HELP - Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change…

News
HELP ▲ +14.2% - Cybin D/B/A Helus Pharma
CP $14.11▲ +14.2%Sep 21, 2026 · ThinkSabio Blog

$HELP - Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit…

News
HELP ▲ +2.8% - Cybin D/B/A Helus Pharma
CP $12.70▲ +2.8%Sep 21, 2026 · ThinkSabio Blog

$HELP - Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026…

News
HELP ▲ +1.3% - Cybin D/B/A Helus Pharma
CP $13.86▲ +1.3%Sep 10, 2026 · ThinkSabio Blog

$HELP - Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York…

SEC 13D/G
HELP - Cybin D/B/A Helus Pharma - SEC Filing Update (09-SEP-2026) | ThinkSabio - Stocks Simplified
$13.95▲ 68.48%Sep 9, 2026 · ThinkSabio Blog

$HELP SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #HELP Cybin D/B/A Helus Pharma : $13.95 Sector: Healthcare | YTD…

SEC 13D/G
HELP - Cybin D/B/A Helus Pharma - SEC Filing Update (09-SEP-2026) | ThinkSabio - Stocks Simplified
$12.93▲ 56.16%Sep 9, 2026 · ThinkSabio Blog

$HELP SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #HELP Cybin D/B/A Helus Pharma : $12.93 Sector: Healthcare | YTD…

News
HELP ▲ +3.2% - Cybin D/B/A Helus Pharma
CP $12.78▲ +3.2%Sep 9, 2026 · ThinkSabio Blog

$HELP - Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York…

News
HELP ▲ +1.1% - Cybin D/B/A Helus Pharma
CP $12.08▲ +1.1%Sep 3, 2026 · ThinkSabio Blog

$HELP - Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York…

SEC 13D/G
HELP - Cybin D/B/A Helus Pharma - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$11.60▲ 40.10%Aug 14, 2026 · ThinkSabio Blog

$HELP SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #HELP Cybin D/B/A Helus Pharma : $11.60 Sector: Healthcare | YTD…

SEC 13D/G
HELP - Cybin D/B/A Helus Pharma - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified
$11.06▲ 33.57%Aug 12, 2026 · ThinkSabio Blog

$HELP SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #HELP Cybin D/B/A Helus Pharma : $11.06 Sector: Healthcare | YTD…